TheProfitWatch

VOR - Vor Biopharma Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
6.88 0.55 (7.99%) -0.01 (-0.13%) 0.0 (0.0%) -0.09 (-1.2%) 0.0 (0.0%) 0.66 (9.75%) -0.04 (-0.57%) -0.12 (-1.71%)

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-12.56
Diluted EPS:
-12.56
Basic P/E:
-0.5916
Diluted P/E:
-0.5916
RSI(14) 1m:
41.94
VWAP:
7.44
RVol:

Events

Period Kind Movement Occurred At

Related News